Who owns ADIAL PHARMACEUTICALS INC?
- Ticker: ADIL
- CUSIP Number: 00688a205
Tip: Access positions for across all investors
Analyze quarterly positions in Adial Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Adial Pharmaceuticals stock
Who bought or sold ADIAL PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Manchester Capital Management | 48k | $49k | 0% | Dec 2024 |
|
| Geode Capital Management | 46k | $45k | 76% | Sep 2024 |
|
| Citadel Advisors | 33k | $33k | 34% | Sep 2024 |
|
| BlackRock | 28k | $28k | 100% | Sep 2024 |
|
| Two Sigma Securities | 27k | $27k | 100% | Sep 2024 |
|
| UBS Group | 4.4k | $4.4k | -95% | Sep 2024 |
|
| Tower Research Capital | 3.9k | $3.9k | -30% | Sep 2024 |
|
| 1620 Investment Advisors | 3.6k | $3.6k | 0% | Sep 2024 |
|
| Bank of America Corporation | 52.00 | $52.000000 | -92% | Sep 2024 |
|
| Abound Wealth Management | 27.00 | $27.999000 | 0% | Dec 2024 |
|
Who sold out of Adial Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Renaissance Technologies | Jun 2024 | 34k | $40k |
| Hrt Financial | Jun 2024 | 29k | $33k |